Health Care Provider Hormonal Recommendations for Treatment of Menstrual Cycle-related Problems - A Vignette-based Study
Journal Title: Journal of Pharmaceutical Research International - Year 2016, Vol 10, Issue 4
Abstract
Background: Combined hormonal contraceptives (CHC) are recommended for “non-contraceptive benefits” for menstrual cycle-related problems. But no evidence-based consensus exists. Our purpose was to assess the clinical choices of health care providers (HCP: pharmacists, physicians, nurses) for menstrual cycle-related scenarios. Methods: A 1-page questionnaire was provided to continuing professional education attendees at events across Canada. They suggested treatments for four common clinical scenarios each involving a different menstrual cycle-related problem. Each case was followed by five to six choices. All potential options included CHC and cyclic progesterone (P4) or medroxyprogesterone (MPA); HCP could choose multiple options. Results: CHC was recommended by 84% of HCP for at least one of four scenarios; 64% chose cyclic P4/MPA at least once. For teenage menorrhagia, 63% chose CHC, 23% cyclic P4/MPA and only 31% ibuprofen. For the 35 year-old smoker with polycystic ovary syndrome (PCOS), 55% discontinued CHC, but 22% suggested switching to higher-dose anti-androgen CHC; 23% chose cyclic MPA, 32% spironolactone and 14% metformin. For a premenopausal fragility fracture, 34% recommended CHC and only 5% cyclic MPA; 17% chose a contraindicated aminobisphosphonate. For perimenopausal VMS, 10% chose CHC, 34% cyclic P4, 21% cyclic MPA. Conclusion: There are significant variations among HCP disciplines for treatment of menstrual cycle-related problems. Contraindications and disadvantages of CHC-based therapies in these scenarios seem to not be recognized by HCP. Evidences for progesterone-based therapies have not been translated into current clinical practice. Few HCP suggested evidence-based non-hormonal treatments. Efforts are needed to translate research-based, physiological menstrual cycle treatments into safe and effective clinical practice.
Authors and Affiliations
Rui Chen, Fatemeh Bejaei, Shan Yi, Tabassum Vali, Jerilynn C. Prior
Keywords
Related Articles
- EP ID EP342428
- DOI 10.9734/BJPR/2016/22046
- Views 80
- Downloads 0
Phytochemical and Nutritional Composition Analysis of Murraya koenigii Linn Leaves
Vegetable is an indispensable constituent of human diet that supplies the body with minerals, vitamins and certain hormone precursors, in addition to protein and energy. The phytochemical and proximate analyses of Murra...
Effect of Aqueous Extract of Guava (Psidium guajava) Leaf on Blood Glucose and Liver Enzymes in Alloxan Induced Diabetic Rats
Aim: The aim of this study is to determine the effect of aqueous extract of Psidium guajava leaf on blood glucose level and liver enzymes of alloxan –induced diabetic rat. Study Design: The animals were grouped into six...
Pharmacokinetic Characterization of Piperaquine in Nigerian Healthy Volunteers after Co-administration with a Commercial Brand of Moringa Tea
This 2-phase cross-over drug–herb interaction study investigated the effect of co-administration of tea prepared from the commercial product of Moringa oleifera on the pharmacokinetic parameters of piperaquine. Fourteen...
Dose Response of Viola odorata on Meiotic and Mitotic Chromosomes of Vicia faba
Aims: Viola odorata is a medicinally important plant. It contains bioactive principle viz violin and probably methyl salicylic ester. The present study was designed to analyze the effect of different doses of this medici...
Investigation of Colorant FD&C Yellow No. 5 Stability in Pharmaceutical Syrup Containing Ascorbic Acid and the Optimal Storage Condition
Stability of colorant FD&C Yellow No. 5 and ascorbic acid (AA) in pharmaceutical KndCold syrup under different storage conditions (Standard conditions, temperature variation, sunlight presence, and sodium hydroxide addit...